N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Assessed by Cystatin C

Cardiovascular Therapeutics

Volumn 31, Issue 3, 2013, Pages 168-173

  Alioglu, Emin ^a   Saygi, Serkan ^b   Turk, Ugur ^c   Kirilmaz, Bahadir ^b   Tuzun, Nurullah ^c   Duman, Can ^b   Tengiz, Istemihan ^a   Yildiz, Serkan ^d   Ercan, Ertugrul ^a  

^a IZMIR UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c Central Hospital Izmir   (Turkey)

^d PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Contrast induced nephropathy; Cystatin C; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS;

ACETYLCYSTEINE; AGED; CONTRAST MEDIA; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 84876476345     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2011.00309.x     Document Type: Article

References (34)

1. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 1989;320:143-149.
2. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4(Suppl 5):S3-S9.
3. Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 2005;64:442-448.
4. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;4:1393-1399.
5. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
6. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992;3:58-65.
7. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251-260.
8. Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004;117:938-947.
9. Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15:407-410.
10. Marenzi G, Assanelli E, Marana I, et al. N-Acetylcysteine and contrast induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-2782.
11. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992;38:1933-1953.
12. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483.
13. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-A review. Clin Chem Lab Med 1999;37:389-395.
14. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: Implication for the assessment of glomerular filtration rate. Clin Chem 1998;44:1535-1539.
15. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-318.
16. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez- Bru C, Grubb A. Cystatin C as a marker of GFR history, indications, and future research. Clin Biochem 2005;38:1-8.
17. Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
18. Julier K, da Silva R, Garcia C et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebocontrolled, multicenter study. Anesthesiology 2003;98:1315-1327.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-S237.
20. Rihal C, Textor S, Grill D, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
21. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-936.
22. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990;150:1237-1242.
23. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-265.
24. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as filtrationmarker in glomerulopathic patients. Kidney Int 1985;28:830-836.
25. Perrone RD, Madis NE, Levey AS. Serum creatinine as a index of renal function: New insights into old concepts. Clin Chem 1992;38:1933-1953.
26. Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-294.
27. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996;56:409-414.
28. Pucci L, Triscornia S, Lucchesi D, et al. Cystatin C and estimates of renal function: Searching for a better measure of kidney function in diabetic patients. Clin Chem 2007;53:480-488.
29. Poletti PA, Saudan P, Platon A et al. I.v. N-acetylcysteine and emergency CT: Use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 2007;189(3):687-692.
30. Kim BJ, Sung KC, Kim BS, et al. Effect of N-Acetylcysteine on cystatin C-Based renaL function after Elective coronary angiography (ENABLE Study): A prospective, randomized trial. Int J Cardiol 2010;138(3):239-245.
31. Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc-preliminary results. Nephrol Dial Transplant 2008;23:1241-1245.
32. Coll E, Botey A, Alvarez L, et al. Seum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29-34.
33. Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61:1453-1461.
34. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-386.